Zimmer Biomet Holdings
- Market cap
- 16.88B
- P/E (TTM)i
- 21.48
- P/Bi
- 1.34
- EPSi
- 3.55
- Div yieldi
- 1.08%
- 52W posi
- 36%
Anonymous reader poll. Unscientific, not investment advice.
About Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
- Founded
- 2001
- CEO
- Mr. Ivan Tornos
- Employees
- 17,000
- Headquarters
- Warsaw, Indiana, United States of America
- Fiscal year end
- 12-31
- Website
- zimmerbiomet.com
Company profile
- Exchange
- US
- Symbol
- ZBH
- Market-cap rank
- #1040
- Listing date
- 1970-01-01
- Market cap
- 16.88B
- Float cap
- 16.83B
- Shares out
- 190.74M
- Float shares
- 190.13M
Sectors & themes
Quote time 2026-10-07 20:02:42 · For reference only, not investment advice and not tailored to your situation.